Filed Provisional Patents for Battery Lifespan Extension Technology: Battery X Rebalancing Technologies has submitted two provisional U.S. patent applications covering proprietary software and ...

Designed for lithium-ion batteries in both 2-4 and 3-10 cell series (S), R-BMS F solutions include Renesas’ industry-leading ...

Bristol Myers Squibb’s examination into whether its heart med Camzyos can spark improvements in patients with non-obstructive ...

Our Automotive Editor, Andy Turudic, chats with Jerry Shi, GM at TI, about preventing thermal runaway in HV batteries while delivering maximum ...

News Channel 11’s John Jenco and Terry Craig discussed tire wear and car configuration following the NASCAR Cup Series race at Bristol Motor Speedway. The Next Gen car has ...

Bristol-Myers Squibb is having a busy holiday period, signing a $4.1 billion deal to acquire cancer drug developer RayzeBio – its second multibillion-dollar M&A deal in the space of a week.

That is the cellular target of both Gilead/Kite's Yescarta (axicabtagene ciloleucel), which was approved by the FDA in 2017 for B-cell lymphoma, and BMS ... for the Federal Circuit ruled however ...

NK Cells Complexed With Bispecific Antibody Yield High Response Rates in Patients With Lymphoma Apr. 4, 2025 — A novel cell therapy approach using cord blood-derived natural killer (NK ...

We may not all find the same things funny but all cultures in the world laugh. Why do we love dogs? Dogs evolved from wolves but why did they choose us humans to be their best friends? 10 Places ...

Breakthrough approach delivers better scaling and power efficiency, but at the cost of new processes like wafer thinning, bonding, and advanced debug.

In particular, organelles called chloroplasts allow plants to capture the energy of the Sun in energy-rich molecules; cell walls allow plants to have rigid structures as varied as wood trunks and ...